BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29305216)

  • 1. Selective glycosidase inhibitors: A patent review (2012-present).
    Wadood A; Ghufran M; Khan A; Azam SS; Jelani M; Uddin R
    Int J Biol Macromol; 2018 May; 111():82-91. PubMed ID: 29305216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosidase inhibitors: a patent review (2008-2013).
    Brás NF; Cerqueira NM; Ramos MJ; Fernandes PA
    Expert Opin Ther Pat; 2014 Aug; 24(8):857-74. PubMed ID: 24958352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinatorial approaches to iminosugars as glycosidase and glycosyltransferase inhibitors.
    Cipolla L; La Ferla B; Gregori M
    Comb Chem High Throughput Screen; 2006 Sep; 9(8):571-82. PubMed ID: 17017877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iminosugar-Cyclopeptoid Conjugates Raise Multivalent Effect in Glycosidase Inhibition at Unprecedented High Levels.
    Lepage ML; Schneider JP; Bodlenner A; Meli A; De Riccardis F; Schmitt M; Tarnus C; Nguyen-Huynh NT; Francois YN; Leize-Wagner E; Birck C; Cousido-Siah A; Podjarny A; Izzo I; Compain P
    Chemistry; 2016 Apr; 22(15):5151-5. PubMed ID: 26917097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent developments in design and synthesis of bicyclic azasugars, carbasugars and related molecules as glycosidase inhibitors.
    Lahiri R; Ansari AA; Vankar YD
    Chem Soc Rev; 2013 Jun; 42(12):5102-18. PubMed ID: 23535828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivalent iminosugars to modulate affinity and selectivity for glycosidases.
    Diot J; García-Moreno MI; Gouin SG; Ortiz Mellet C; Haupt K; Kovensky J
    Org Biomol Chem; 2009 Jan; 7(2):357-63. PubMed ID: 19109682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iminosugars as therapeutic agents: recent advances and promising trends.
    Nash RJ; Kato A; Yu CY; Fleet GW
    Future Med Chem; 2011 Sep; 3(12):1513-21. PubMed ID: 21882944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural and synthetic iminosugars as carbohydrate processing enzyme inhibitors for cancer therapy.
    Wrodnigg TM; Steiner AJ; Ueberbacher BJ
    Anticancer Agents Med Chem; 2008 Jan; 8(1):77-85. PubMed ID: 18220507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycomimetics at the mirror: medicinal chemistry of L-iminosugars.
    D'Alonzo D; Guaragna A; Palumbo G
    Curr Med Chem; 2009; 16(4):473-505. PubMed ID: 19199917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fullerene-sp2-iminosugar balls as multimodal ligands for lectins and glycosidases: a mechanistic hypothesis for the inhibitory multivalent effect.
    Rísquez-Cuadro R; García Fernández JM; Nierengarten JF; Ortiz Mellet C
    Chemistry; 2013 Dec; 19(49):16791-803. PubMed ID: 24150869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bicyclic hybrid sugars as glycosidase inhibitors: synthesis and comparative study of inhibitory activities of fused oxa-oxa, oxa-aza, and oxa-carbasugar hybrid molecules.
    Ansari AA; Rajasekaran P; Khan MM; Vankar YD
    J Org Chem; 2014 Feb; 79(4):1690-9. PubMed ID: 24456236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors against glycosidases as medicines.
    Kajimoto T; Node M
    Curr Top Med Chem; 2009; 9(1):13-33. PubMed ID: 19199994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and glycosidase inhibition potency of all-trans substituted 1-C-perfluoroalkyl iminosugars.
    Massicot F; Plantier-Royon R; Vasse JL; Behr JB
    Carbohydr Res; 2018 Jul; 464():2-7. PubMed ID: 29777947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of tricyclic benzimidazole-iminosugars as potential glycosidase inhibitors via a Mitsunobu reaction.
    Yan L; Lui H; Sun J; Gao L; Lu X; Li X; Chen H
    Carbohydr Res; 2019 Nov; 485():107807. PubMed ID: 31520817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imino sugars and glycosyl hydrolases: historical context, current aspects, emerging trends.
    Stütz AE; Wrodnigg TM
    Adv Carbohydr Chem Biochem; 2011; 66():187-298. PubMed ID: 22123190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of nonnatural L-iminosugar C,C-glycosides, a new class of C-branched iminosugars, as glycosidase inhibitors.
    Désiré J; Debbah Z; Gueyrard D; Marrot J; Blériot Y; Kato A
    Carbohydr Res; 2023 Oct; 532():108903. PubMed ID: 37523839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic applications of sugar-mimicking glycosidase inhibitors.
    Asano N; Kato A; Watson AA
    Mini Rev Med Chem; 2001 Jul; 1(2):145-54. PubMed ID: 12374106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosidase inhibitors from the roots of Glyphaea brevis.
    Gossan DP; Alabdul Magid A; Kouassi-Yao PA; Behr JB; Ahibo AC; Djakouré LA; Harakat D; Voutquenne-Nazabadioko L
    Phytochemistry; 2015 Jan; 109():76-83. PubMed ID: 25468536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of tricyclic quinazolinone-iminosugars as potential glycosidase inhibitors via a Mitsunobu reaction.
    Sun J; Kang Y; Gao L; Lu X; Ju H; Li X; Chen H
    Carbohydr Res; 2019 May; 478():10-17. PubMed ID: 31039450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functionalization of glycals leading to 2-deoxy-O-glycosides, aminosugars, nitrosugars and glycosidase inhibitors: our experience.
    Lahiri R; Dharuman S; Vankar YD
    Chimia (Aarau); 2012; 66(12):905-12. PubMed ID: 23394274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.